Exact Mass: 424.17600360000006
Exact Mass Matches: 424.17600360000006
Found 500 metabolites which its exact mass value is equals to given mass value 424.17600360000006
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Clindamycin
C18H33ClN2O5S (424.17985980000003)
Clindamycin is a semisynthetic lincosamide antibiotic that has largely replaced lincomycin due to an improved side effect profile. Clindamycin inhibits bacterial protein synthesis by binding to bacterial 50S ribosomal subunits. It may be bacteriostatic or bactericidal depending on the organism and drug concentration. Clindamycin, also known as cleocin or 7-CDL, belongs to the class of organic compounds known as proline and derivatives. Proline and derivatives are compounds containing proline or a derivative thereof resulting from reaction of proline at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Clindamycin is a drug. Clindamycin is a semisynthetic lincosamide antibiotic that has largely replaced lincomycin due to an improved side effect profile. Clindamycin is a very strong basic compound (based on its pKa). In humans, clindamycin is involved in clindamycin action pathway. Orally and parenterally administered clindamycin has been associated with severe colitis (pseudomembranous colitis) which may result in patient death. Use of the topical formulation of clindamycin results in absorption of the antibiotic from the skin surface. Clindamycin is a potentially toxic compound. Rapidly absorbed after oral administration with peak serum concentrations observed after about 45 minutes. Oral; topical; parenteral (intramuscular, intravenous). Systemic/vaginal clindamycin inhibits protein synthesis of bacteria by binding to the 50S ribosomal subunits of the bacteria. Clindamycin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=18323-44-9 (retrieved 2024-06-28) (CAS RN: 18323-44-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
N,N'-diacetylchitobiose
C16H28N2O11 (424.16930179999997)
N,N-diacetylchitobiose, also known as (GlcNAc)2, is classified as a member of the Acylaminosugars. Acylaminosugars are organic compounds containing a sugar linked to a chain through N-acyl group. N,N-diacetylchitobiose is considered to be soluble (in water) and acidic. N,N-diacetylchitobiose may be a unique E.coli metabolite N,N'-Diacetylchitobiose is a dimer of β(1,4) linked N-acetyl-D glucosamine. N,N'-Diacetylchitobiose is the hydrolysate of chitin and can be used as alternative carbon source by?E. coli[1].
2,2-Dimethyl-3-(4-methoxyphenyl)-4-ethyl-7-hydroxy-2H-1-benzopyran-8-methanol diacetate
Sophoraflavanone G
Sophoraflavanone G (Kushenol F) is iaolated from Sophora flavescens and shows anti-tumor and anti-inflammatory properties.? Sophoraflavanone G (Kushenol F) induces MDA-MB-231 and HL-60 cells apoptosis through suppression of MAPK-related pathways. Sophoraflavanone G. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=97938-30-2 (retrieved 2024-10-11) (CAS RN: 97938-30-2). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Trimethobenzamide hydrochloride
C21H29ClN2O5 (424.17648940000004)
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Trimethobenzamide hydrochloride is a blocker of the D2 receptor. Trimethobenzamide is an antiemetic used to prevent nausea and vomiting.
beta-Mangostin
Beta-Mangostin is a member of xanthones. beta-Mangostin is a natural product found in Garcinia oliveri, Garcinia cowa, and other organisms with data available. From Garcinia mangostana (mangosteen). beta-Mangostin is found in fruits and purple mangosteen. beta-Mangostin is found in fruits. beta-Mangostin is from Garcinia mangostana (mangosteen). beta-Mangostin (β-Mangostin) is a xanthone compound present in Cratoxylum arborescens, with antibacterial and antimalarial activities. beta-Mangostin exhibits antimycobacterial activity against Mycobacterium tuberculosis with an MIC of 6.25 μg/mL. beta-Mangostin possesses in vitro antimalarial activity against Plasmodium falciparum, with an IC50 of 3.00 μg/mL. beta-Mangostin has potent anticancer activity against various cancers (such as hepatocellular carcinoma, leukaemic)[1][2][3][4]. beta-Mangostin (β-Mangostin) is a xanthone compound present in Cratoxylum arborescens, with antibacterial and antimalarial activities. beta-Mangostin exhibits antimycobacterial activity against Mycobacterium tuberculosis with an MIC of 6.25 μg/mL. beta-Mangostin possesses in vitro antimalarial activity against Plasmodium falciparum, with an IC50 of 3.00 μg/mL. beta-Mangostin has potent anticancer activity against various cancers (such as hepatocellular carcinoma, leukaemic)[1][2][3][4].
Taraxinic acid glucosyl ester
Constituent of Taraxacum officinale (dandelion). Taraxinic acid glucosyl ester is found in many foods, some of which are coffee and coffee products, dandelion, tea, and alcoholic beverages. Taraxinic acid glucosyl ester is found in alcoholic beverages. Taraxinic acid glucosyl ester is a constituent of Taraxacum officinale (dandelion).
(S)-3',4',5,7-Tetrahydroxy-5',8-diprenylflavanone
(S)-3,4,5,7-Tetrahydroxy-5,8-diprenylflavanone is found in herbs and spices. (S)-3,4,5,7-Tetrahydroxy-5,8-diprenylflavanone is isolated from Glycyrrhiza uralensis (Chinese licorice). Isolated from Glycyrrhiza uralensis (Chinese licorice). Gancaonin E is found in herbs and spices.
Dulxanthone C
Dulxanthone C is found in fruits. Dulxanthone C is a constituent of the stem bark of Garcinia dulcis (mundu)
Kuwanon E
Kuwanon E is found in fruits. Kuwanon E is a constituent of Morus alba (white mulberry)
Glisoflavanone
(±)-Glisoflavanone is found in herbs and spices. (±)-Glisoflavanone is a constituent of Glycyrrhiza uralensis (Chinese licorice). Constituent of Glycyrrhiza uralensis (Chinese licorice). (±)-Glisoflavanone is found in herbs and spices.
1,7-Dihydroxy-3,6-dimethoxy-2,8-diprenylxanthone
1,7-Dihydroxy-3,6-dimethoxy-2,8-diprenylxanthone is found in fruits. 1,7-Dihydroxy-3,6-dimethoxy-2,8-diprenylxanthone is a constituent of Garcinia mangostana (mangosteen). Constituent of Garcinia mangostana (mangosteen). 1,7-Dihydroxy-3,6-dimethoxy-2,8-diprenylxanthone is found in fruits.
(±)-2',4',5,7-Tetrahydroxy-3',8-diprenylisoflavanone
(±)-2,4,5,7-Tetrahydroxy-3,8-diprenylisoflavanone is found in herbs and spices. (±)-2,4,5,7-Tetrahydroxy-3,8-diprenylisoflavanone is isolated from Phaseolus lunatus (butter bean) seedlings under stress and from Glycyrrhiza glabra (licorice Isolated from Phaseolus lunatus (butter bean) seedlings under stress and from Glycyrrhiza glabra (licorice). (±)-2,4,5,7-Tetrahydroxy-3,8-diprenylisoflavanone is found in tea, herbs and spices, and pulses.
3-Methyl-2-butenyl-(-)-piperitol
3-Methyl-2-butenyl-(-)-piperitol is found in herbs and spices. 3-Methyl-2-butenyl-(-)-piperitol is a constituent of Zanthoxylum piperitum (Japanese pepper tree). Constituent of Zanthoxylum piperitum (Japanese pepper tree). 3-Methyl-2-butenyl-(-)-piperitol is found in herbs and spices.
D-Cloprostenol
C22H29ClO6 (424.16525640000003)
8-Acetylneosolaniol
Calix[4]arene
Methanone, ((2R,5R)-5-(((5-fluoro-2-pyridinyl)oxy)methyl)-2-methyl-1-piperidinyl)(5-fluoro-2-(2-pyrimidinyl)phenyl)-
Forsmann antigen
C16H28N2O11 (424.16930179999997)
Galnac-1-4-glcnac
C16H28N2O11 (424.16930179999997)
Lacdinac
C16H28N2O11 (424.16930179999997)
N,N'-Diacetylchitobiose is a dimer of β(1,4) linked N-acetyl-D glucosamine. N,N'-Diacetylchitobiose is the hydrolysate of chitin and can be used as alternative carbon source by?E. coli[1].
Sophoraflavanone G
Sophoraflavanone G (Kushenol F) is iaolated from Sophora flavescens and shows anti-tumor and anti-inflammatory properties.? Sophoraflavanone G (Kushenol F) induces MDA-MB-231 and HL-60 cells apoptosis through suppression of MAPK-related pathways[1][2]. Sophoraflavanone G (Kushenol F) is iaolated from Sophora flavescens and shows anti-tumor and anti-inflammatory properties.? Sophoraflavanone G (Kushenol F) induces MDA-MB-231 and HL-60 cells apoptosis through suppression of MAPK-related pathways[1][2].
SPIRADOLINE
C22H30Cl2N2O2 (424.16842199999996)
Crepidiaside B
Crepidiaside b is a member of the class of compounds known as O-glycosyl compounds. O-glycosyl compounds are glycoside in which a sugar group is bonded through one carbon to another group via a O-glycosidic bond. Crepidiaside b is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Crepidiaside b can be found in chicory and endive, which makes crepidiaside b a potential biomarker for the consumption of these food products.
Cowaxanthone B
Cowaxanthone B is a natural product found in Garcinia cowa and Cratoxylum arborescens with data available.
Kuwanon E
Kuwanon E is a member of flavanones. 4H-1-Benzopyran-4-one, 2-(5-((2E)-3,7-dimethyl-2,6-octadienyl)-2,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-, (2S)- is a natural product found in Morus lhou, Morus mongolica, and other organisms with data available.
Sophoraflavanone_G
Sophoraflavanone G is a tetrahydroxyflavanone having a structure of naringenin bearing an additional hydroxyl substituent at position 2 as well as a (2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl (lavandulyl) substituent at position 8. It has a role as an antioxidant, an antimalarial, an antimicrobial agent and a plant metabolite. It is a tetrahydroxyflavanone, a member of 4-hydroxyflavanones and a (2S)-flavan-4-one. It is functionally related to a (S)-naringenin. Sophoraflavanone G is a natural product found in Sophora stenophylla, Sophora moorcroftiana, and other organisms with data available. A tetrahydroxyflavanone having a structure of naringenin bearing an additional hydroxyl substituent at position 2 as well as a (2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl (lavandulyl) substituent at position 8. Sophoraflavanone G (Kushenol F) is iaolated from Sophora flavescens and shows anti-tumor and anti-inflammatory properties.? Sophoraflavanone G (Kushenol F) induces MDA-MB-231 and HL-60 cells apoptosis through suppression of MAPK-related pathways[1][2]. Sophoraflavanone G (Kushenol F) is iaolated from Sophora flavescens and shows anti-tumor and anti-inflammatory properties.? Sophoraflavanone G (Kushenol F) induces MDA-MB-231 and HL-60 cells apoptosis through suppression of MAPK-related pathways[1][2].
FLLL-31
Tetramethylcurcumin (FLLL31), derived from curcumin, specifically suppresses the phosphorylation of STAT3 by binding selectively to Janus kinase 2 and the STAT3 Src homology-2 domain. Tetramethylcurcumin exhibits anti-inflammatory and anti-cancer effects[1][2].
[3aR-(3aR*,5E,9Z,11aR*)]- 2,3,3a,4,7,8,11,11a-Octahydro-6-methyl-3-methylene-2-oxo-, beta-D-glucopyranosyl ester cyclodeca[b]furan-10-carboxylic acid
SOPHORAFLAVANONE L
A trihydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5, 2 and 4, a prenyl group at position 8 and a prenyloxy group at position 7. Isolated from the roots of Sophora flavescens, it exhibits cytotoxicity towards KB epidermoid carcinoma cell line.
Orientanol E
arugosin A (lactol form)
A dibenzooxepine that is dibenzo[b,e]oxepin-11(6H)-one which is substituted by hydroxy groups at positions 1, 6, and 10, a 3,3-dimethylallyl group at position 2, a 3,3-dimethylallyloxy group at position 7, and a methyl group at position 8.
arugosin B
A dibenzooxepine that is dibenzo[b,e]oxepin-11(6H)-one substituted by hydroxy groups at positions 1, 6 and 10, a methyl group at position 8, a prenyl group at position 4 and a prenyloxy group at position 7. Isolated from Aspergillus, it exhibits antibacterial activity.
24-Dihydroxy-5-(1,1-dimethylallyl)-6-C-prenylpinocembrin
Tetrapterol G
Lonchocarpol D1
Variecoxanthone C
A member of the class of xanthones that is 9H-xanthen-9-one substituted by a (3,3-dimethyoxiran-2-yl)methyl group at position 5, a hydroxy group at position 8, a hydroxymethyl group at position 1, a methyl group at position 3 and a prenyloxy group at position 2. It has been isolated from Aspergillus.
Lespedezol D5
Bonanniol A
Lonchocarpol C1
Arugosin C
An organic heterotetracyclic compound that is 1,12a-dihydrochromeno[4,5-bc][1]benzoxepin-7(2H)-one substituted by a hydroxy group at position 8, a 2-hydroxypropan-2-yl group at position 1, a methyl group at position 4 and a prenyl group at position 9. Isolated from Aspergillus, it exhibits inhibitory activity against hepatitis C protease.
Flemiflavanone D
6,8-Diprenyleriodictyol
[4R-(4R*,5S*,6S*,7S*,10R*,11E)]- 3-[(Acetyloxy)methyl]-5,6,7,8,9,10-hexahydro-6,7-dihydroxy-5,6,10-trimethyl-4-(1-oxopropoxy)-7,10-epoxycyclodeca[b]furan-2(4H)-one
paratocarpin G
(2S)-5,7,2,4-Tetrahydroxy-8-prenyl-5-(1,1-dimethylallyl)flavanone
remangiflavanone B
A tetrahydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5, 7, 2 and 4 and a lavandulyl group at position 8. Isolated from Physena madagascariensis, it exhibits antibacterial activity.
Exiguaflavanone A
A tetrahydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5, 7, 2 and 6 and a lavandulyl group at position 8. Isolated from Sophora exigua and Artemisia indica, it exhibits antimalarial activity.
Sanggenol A
Sanggenol A is a natural product found in Morus cathayana and Morus alba with data available.
diplacone
norkurarinone
Sophoraflavanone G (Kushenol F) is iaolated from Sophora flavescens and shows anti-tumor and anti-inflammatory properties.? Sophoraflavanone G (Kushenol F) induces MDA-MB-231 and HL-60 cells apoptosis through suppression of MAPK-related pathways[1][2]. Sophoraflavanone G (Kushenol F) is iaolated from Sophora flavescens and shows anti-tumor and anti-inflammatory properties.? Sophoraflavanone G (Kushenol F) induces MDA-MB-231 and HL-60 cells apoptosis through suppression of MAPK-related pathways[1][2].
DIHYDROMUNDULETONE
Dihydromunduletone (DHM) is a rotenoid derivative and a selective, potent adhesion G protein-coupled receptor (aGPCR) (GPR56 and GPR114/ADGRG5) antagonist with an IC 50 of 20.9 μM for GPR56, but not inhibit GPR110 or class A GPCRs[1].
9-(3-Hydroxy-3-methylglutaroyloxy)-abscisic acid|beta-hydroxy-beta-methylglutarylhydroxyabscisic acid
15-glucopyranosyloxy-2-oxo-guaia-3,11(13)-dien-1beta,5alpha,6beta,7alpha,10alphaH-12,6-olide
2-(3,5-dihydroxyphenyl)-5,7-dihydroxy-6,8-bis(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one
(S)-Diplacone|6-geranyl-3,4,5,7-tetrahydroxy-flavanone|6-geranyl-3,4,5,7-tetrahydroxyflavanone|Diplacone|nymphaenol A|nymphaeol-A|nymphaerol A
1-(2,4-dihydroxyphenyl)-3-[8-hydroxy-2-methyl-2-(4-hydroxy-4-methyl-2-pentenyl)-2h-1-benzopyran-5-yl]-1-propanone
vexibinol
Sophoraflavanone G (Kushenol F) is iaolated from Sophora flavescens and shows anti-tumor and anti-inflammatory properties.? Sophoraflavanone G (Kushenol F) induces MDA-MB-231 and HL-60 cells apoptosis through suppression of MAPK-related pathways[1][2]. Sophoraflavanone G (Kushenol F) is iaolated from Sophora flavescens and shows anti-tumor and anti-inflammatory properties.? Sophoraflavanone G (Kushenol F) induces MDA-MB-231 and HL-60 cells apoptosis through suppression of MAPK-related pathways[1][2].
8-(3,4-dihydroxyphenyl)-5-hydroxy-2,2-dimethyl-10-(3-methylbut-2-enyl)-3,4,7,8-tetrahydropyrano[3,2-g]chromen-6-one
11,13alpha-dihydroixerin Z|11beta,13-dihydroixerin Z
2(S)-5,7-dihydroxy-5-prenyl-[2,2-(3-hydroxy)-dimethylpyrano]-(5,6:3,4)flavanone
(2R,3R)-3-geranyl-2,3-trans-5,7,4-trihydroxyflavonol
7,7-methanediylbis(3,4-dihydro-8-hydroxy-3,4,5-trimethyl-6H-isochromen-6-one)|dicitrinol|dicitrinone C
2,3,4,4-tetrahydroxy-3-[6-hydroxy-3,7-dimethyl-2(E),7-octadienyl]chalcone
11beta-hydroxyleucodin 11-O-beta-D-glucopyranoside|11beta-hydroxyleucodin-11-O-beta-glucopyranoside|11beta-hydroxyleucodin-O-beta-D-glucopyranoside|11beta-hydroxyleukodin 11-O-beta-glucopyranoside|11??-Hydroxyleukodin 11-O-??-glucopyranoside
beta-hydroxy-beta-methylglutaryl ester of 8-hydroxyabscisic acid
3,4,5,7-Tetrahydroxy-6,8-diprenyl-2,3-dihydroisoflavone
8beta,9alpha-dihydroxy-5alpha,9betaH-lindan-4(15),7(13)-dien-8alpha,12-olide-8beta-O-beta-D-glucopyranoside|chloranthalactone E 8-O-beta-D-glucopyranoside
2-[3-(3-Methyl-2-butenyl)-4-hydroxyphenyl]-3,5,7-trihydroxy-8-(3-methyl-2-butenyl)-3,4-dihydro-2H-1-benzopyran-4-one
3alpha-acetoxy-5beta-(4-acetoxytigloyloxy)-7-acetoxycarvotanacetone
4,5,7-trihydroxy-6-[6-hydroxy-3,7-dimethyl-2,7-octadienyl]flavanone|mimolone B
5,4-dihydroxy-6-(3-methylbut-2-enyl)-5-hydroxyisopropyldihydrofurano[2,3:7,8]isoflavone|isosenegalensein
1,5-dihydroxy-3,8-dimethoxy-2-(3,3-dimethyl-2-propenyl)-7-(3,3-dimethyl-2-propenyl)xanthone|phylattrin
CRATOXYARBORENONE C
A member of the class of xanthones that is 9H-xanthen-9-one substituted by hydroxy groups at positions 1 and 3, methoxy groups at positions 5 and 7 and two isoprenyl groups at positions 2 and 8 respectively. It is isolated from Cratoxylum Sumatranum and exhibits cytotoxicity towards the KB (human oral epidermoid) cancer cell line
(-)-(7R,8R)-4,7,9,8,9-pentahydroxy-3,3,5-trimethoxy-8-O-4-neolignan|3-(4-{[(1R,2R)-1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]oxy}-3,5-dimethoxyphenyl)propane-1,2-diol|casearialignan D
2alpha-hydroperoxy-8-O-isobutyryl-9alpha-acetoxycumambrin B|2??-Hydroperoxy-8-O-isobutyryl-9??-acetoxycumambrin B
8alpha-(4-hydroxymethacryloyloxy)-10alpha-hydroxy-1,13-dimethoxy-hirsutinolide
(+/-)-euchrestaflavanone B|(S)-form-Euchrestaflavanone B|5,7,2,4-tetrahydroxy-6,5-diprenylflavanone|cudraflavanone D|euchrestaflavanone B
3-(18,19-dihydro-19-hydroxygeranyloxy)-1,8-dihydroxy-6-methylanthraquinone|3-O-(3,7-dimethyl-7-hydroxyoct-2-enyl)-emodin
(1R*,4R*,8S*,10R*)-1,4-epoxy-1-ethoxy-8,13-diacetoxy-10-hydroxy-germacra-5E,7(11)-dien-6,12-olide
O1-Me,8-propanoyl,13-Ac-1,4-Epoxy-1,8,10,13-tetrahydroxy-5,7(11)-germacradien-12,6-olide
C21H28O9_1-O-{[(3aS,6Z,10E,11aR)-10-Methyl-3-methylene-2-oxo-2,3,3a,4,5,8,9,11a-octahydrocyclodeca[b]furan-6-yl]carbonyl}-beta-D-glucopyranose
C21H28O9_2-Hydroxycyclohexyl 2-O-[(2E)-3-(4-hydroxyphenyl)-2-propenoyl]-beta-D-glucopyranoside
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3aS,6Z,10E,11aR)-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate
2-oxapentacyclo[21.2.2.13,7.110,14.015,20]nonacosa-1(25),3,5,7(29),10(28),11,13,15(20),16,18,23,26-dodecaene-4,13,18-triol
CONFIDENCE Predicted
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3aS,6Z,10E,11aR)-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate_major
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3aS,6Z,10E,11aR)-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate_7.2\\%
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3aS,6Z,10E,11aR)-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate_5.5\\%
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3aS,6Z,10E,11aR)-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate_4.0\\%
Ala Phe Gly Met
C19H28N4O5S (424.17803180000004)
Ala Phe Met Gly
C19H28N4O5S (424.17803180000004)
Ala Gly Phe Met
C19H28N4O5S (424.17803180000004)
Ala Gly Met Phe
C19H28N4O5S (424.17803180000004)
Ala Met Phe Gly
C19H28N4O5S (424.17803180000004)
Ala Met Gly Phe
C19H28N4O5S (424.17803180000004)
Cys Phe Gly Val
C19H28N4O5S (424.17803180000004)
Cys Phe Val Gly
C19H28N4O5S (424.17803180000004)
Cys Gly Phe Val
C19H28N4O5S (424.17803180000004)
Cys Gly Val Phe
C19H28N4O5S (424.17803180000004)
Cys Val Phe Gly
C19H28N4O5S (424.17803180000004)
Cys Val Gly Phe
C19H28N4O5S (424.17803180000004)
Asp Gly His Pro
C17H24N6O7 (424.17063939999997)
Asp Gly Pro His
C17H24N6O7 (424.17063939999997)
Asp His Gly Pro
C17H24N6O7 (424.17063939999997)
Asp His Pro Gly
C17H24N6O7 (424.17063939999997)
Asp Pro Gly His
C17H24N6O7 (424.17063939999997)
Asp Pro His Gly
C17H24N6O7 (424.17063939999997)
Phe Ala Gly Met
C19H28N4O5S (424.17803180000004)
Phe Ala Met Gly
C19H28N4O5S (424.17803180000004)
Phe Cys Gly Val
C19H28N4O5S (424.17803180000004)
Phe Cys Val Gly
C19H28N4O5S (424.17803180000004)
Phe Gly Ala Met
C19H28N4O5S (424.17803180000004)
Phe Gly Cys Val
C19H28N4O5S (424.17803180000004)
Phe Gly Met Ala
C19H28N4O5S (424.17803180000004)
Phe Gly Val Cys
C19H28N4O5S (424.17803180000004)
Phe Met Ala Gly
C19H28N4O5S (424.17803180000004)
Phe Met Gly Ala
C19H28N4O5S (424.17803180000004)
Phe Val Cys Gly
C19H28N4O5S (424.17803180000004)
Phe Val Gly Cys
C19H28N4O5S (424.17803180000004)
Gly Ala Phe Met
C19H28N4O5S (424.17803180000004)
Gly Ala Met Phe
C19H28N4O5S (424.17803180000004)
Gly Cys Phe Val
C19H28N4O5S (424.17803180000004)
Gly Cys Val Phe
C19H28N4O5S (424.17803180000004)
Gly Asp His Pro
C17H24N6O7 (424.17063939999997)
Gly Asp Pro His
C17H24N6O7 (424.17063939999997)
Gly Phe Ala Met
C19H28N4O5S (424.17803180000004)
Gly Phe Cys Val
C19H28N4O5S (424.17803180000004)
Gly Phe Met Ala
C19H28N4O5S (424.17803180000004)
Gly Phe Val Cys
C19H28N4O5S (424.17803180000004)
Gly His Asp Pro
C17H24N6O7 (424.17063939999997)
Gly His Pro Asp
C17H24N6O7 (424.17063939999997)
Gly Met Ala Phe
C19H28N4O5S (424.17803180000004)
Gly Met Phe Ala
C19H28N4O5S (424.17803180000004)
Gly Pro Asp His
C17H24N6O7 (424.17063939999997)
Gly Pro His Asp
C17H24N6O7 (424.17063939999997)
Gly Val Cys Phe
C19H28N4O5S (424.17803180000004)
Gly Val Phe Cys
C19H28N4O5S (424.17803180000004)
His Asp Gly Pro
C17H24N6O7 (424.17063939999997)
His Asp Pro Gly
C17H24N6O7 (424.17063939999997)
His Gly Asp Pro
C17H24N6O7 (424.17063939999997)
His Gly Pro Asp
C17H24N6O7 (424.17063939999997)
His Pro Asp Gly
C17H24N6O7 (424.17063939999997)
His Pro Gly Asp
C17H24N6O7 (424.17063939999997)
Met Ala Phe Gly
C19H28N4O5S (424.17803180000004)
Met Ala Gly Phe
C19H28N4O5S (424.17803180000004)
Met Phe Ala Gly
C19H28N4O5S (424.17803180000004)
Met Phe Gly Ala
C19H28N4O5S (424.17803180000004)
Met Gly Ala Phe
C19H28N4O5S (424.17803180000004)
Met Gly Phe Ala
C19H28N4O5S (424.17803180000004)
β-D-Glucopyranosiduronic acid, 2-(1H-indol-4-yloxy)-1-[[(1-methylethyl)amino]methyl]ethyl
Pro Asp Gly His
C17H24N6O7 (424.17063939999997)
Pro Asp His Gly
C17H24N6O7 (424.17063939999997)
Pro Gly Asp His
C17H24N6O7 (424.17063939999997)
Pro Gly His Asp
C17H24N6O7 (424.17063939999997)
Pro His Asp Gly
C17H24N6O7 (424.17063939999997)
Pro His Gly Asp
C17H24N6O7 (424.17063939999997)
Val Cys Phe Gly
C19H28N4O5S (424.17803180000004)
Val Cys Gly Phe
C19H28N4O5S (424.17803180000004)
Val Phe Cys Gly
C19H28N4O5S (424.17803180000004)
Val Phe Gly Cys
C19H28N4O5S (424.17803180000004)
Val Gly Cys Phe
C19H28N4O5S (424.17803180000004)
Val Gly Phe Cys
C19H28N4O5S (424.17803180000004)
(+)-5-trans Cloprostenol
C22H29ClO6 (424.16525640000003)
(+)-15-epi Cloprostenol
C22H29ClO6 (424.16525640000003)
Cloprostenol
C22H29ClO6 (424.16525640000003)
D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents D012102 - Reproductive Control Agents > D008186 - Luteolytic Agents
(+)-Cloprostenol
C22H29ClO6 (424.16525640000003)
Taraxinic acid glucosyl ester
10-[4-(1-naphthalenyl)phenyl]-9-anthracenyl]-Boronic acid[
10-[4-(2-naphthalenyl)phenyl]-9-anthracenyl]-Boronic acid
[4-[9-(Naphthalen-2-yl)anthracen-10-yl]phenyl]boronic acid
2-[[4-[(2-cyanoethyl)(2-phenylethyl)amino]phenyl]azo]-5-nitrobenzonitrile
N,N-Diacetylchitobiose
C16H28N2O11 (424.16930179999997)
The N,N-diacetylated derivative of chitobiose, but with no stereodesignation for the anomeric carbon atom. N,N'-Diacetylchitobiose is a dimer of β(1,4) linked N-acetyl-D glucosamine. N,N'-Diacetylchitobiose is the hydrolysate of chitin and can be used as alternative carbon source by?E. coli[1].
Anileridine hydrochloride
C22H30Cl2N2O2 (424.16842199999996)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent
(3S,4S,5S)-3-amino-4,5-dihydroxy-6-[[(1S)-1-[(3S)-8-hydroxy-1-oxo-3,4-dihydroisochromen-3-yl]-3-methylbutyl]amino]-6-oxohexanoic acid
GlcNAc1-beta-3GalNAc
C16H28N2O11 (424.16930179999997)
beta-D-GlcpNAc-(1->6)-D-GalpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide consisting of N-acetyl-D-galactosamine having a N-acetyl-beta-D-glucosaminyl residue attached at the 6-position.
2-Acetamido-6-O-(2-acetamido-2-deoxy-a-D-galactopyranosyl)-2-deoxy-D-galactopyranose
C16H28N2O11 (424.16930179999997)
2-Acetamido-4-O-(2-acetamido-2-deoxy-a-D-galactopyranosyl)-2-deoxy-D-galactopyranose
C16H28N2O11 (424.16930179999997)
SPIRADOLINE
C22H30Cl2N2O2 (424.16842199999996)
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics
12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one
C27H24N2O3 (424.17868339999995)
(4,11-Diacetyloxy-10-hydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-2-yl)methyl acetate
[(2R,4S,10R,11S)-10,11-diacetyloxy-4-hydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-2-yl]methyl acetate
2-(3,4-dichlorophenyl)-N-methyl-N-[7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide
C22H30Cl2N2O2 (424.16842199999996)
beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc
C16H28N2O11 (424.16930179999997)
beta-D-GalpNAc-(1->4)-D-GlcpNAc with beta configuration at the anomeric centre.
beta-D-GlcpNAc-(1->3)-alpha-D-GalpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide comprising an N-acetyl-beta-D-glucosamine residue linked (1->3) to an N-acetyl-beta-D-galactosamine residue at the reducing end.
beta-D-GlcpNAc-(1->6)-alpha-D-GalpNAc
C16H28N2O11 (424.16930179999997)
beta-D-GlcpNAc-(1->6)-D-GalpNAc in which the anomeric configuration of the reducing-end GalNAc residue is alpha.
N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-alpha-D-glucosamine
C16H28N2O11 (424.16930179999997)
N-[1-(3-methoxyphenyl)-3-(1-naphthalenylamino)-3-oxopropyl]benzamide
C27H24N2O3 (424.17868339999995)
methyl 3-[[2-[4-(furan-2-carbonyl)piperazin-1-yl]acetyl]amino]-6-methyl-1H-indole-2-carboxylate
7-[[1-(2-oxolanylmethyl)-5-tetrazolyl]-(1-pyrrolidinyl)methyl]-5H-[1,3]dioxolo[4,5-g]quinolin-6-one
beta-D-GalpNAc-(1->3)-beta-D-GlcpNAc
C16H28N2O11 (424.16930179999997)
2-Acetamido-6-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-2-deoxy-D-glucopyranose
C16H28N2O11 (424.16930179999997)
(2S,4R)-N-[(1S,2S)-2-chloro-1-[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-2-oxanyl]propyl]-1-methyl-4-propyl-2-pyrrolidinecarboxamide
C18H33ClN2O5S (424.17985980000003)
N-acetyl-D-galactosaminyl-(1->3)-N-acetyl-D-galactosamine
C16H28N2O11 (424.16930179999997)
beta-D-GalpNAc-(1->3)-alpha-D-GalpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide comprised of N-acetyl-alpha-D-galactosamine having an N-acetyl-D-galactosaminyl residue attached at the 3-position via a beta-linkage.
2-acetamido-4-O-(2-acetamido-2-deoxy-beta-D-galactopyranosyl)-2-deoxy-alpha-D-galactopyranose
C16H28N2O11 (424.16930179999997)
1,3-benzodioxol-5-yl-[(1R,5S)-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methanone
C27H24N2O3 (424.17868339999995)
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-(2-oxo-2-piperidin-1-ylethyl)-3,6-dihydro-2H-pyran-3-yl]-2-methoxybenzenesulfonamide
C20H28N2O6S (424.16679880000004)
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-2-methoxybenzenesulfonamide
C20H28N2O6S (424.16679880000004)
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-(2-oxo-2-piperidin-1-ylethyl)-3,6-dihydro-2H-pyran-3-yl]-2-methoxybenzenesulfonamide
C20H28N2O6S (424.16679880000004)
N-[(2R,3S,6S)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
C21H29ClN2O5 (424.17648940000004)
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-cyclopentylacetamide
C20H28N2O6S (424.16679880000004)
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-2-methoxybenzenesulfonamide
C20H28N2O6S (424.16679880000004)
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-2-methoxybenzenesulfonamide
C20H28N2O6S (424.16679880000004)
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-2-methoxybenzenesulfonamide
C20H28N2O6S (424.16679880000004)
N-[(2S,3R,6S)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]oxane-4-carboxamide
C21H29ClN2O5 (424.17648940000004)
N-[(2S,3R,6R)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]oxane-4-carboxamide
C21H29ClN2O5 (424.17648940000004)
N-[(2S,3S,6S)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
C21H29ClN2O5 (424.17648940000004)
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
C20H28N2O6S (424.16679880000004)
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-cyclopentylacetamide
C20H28N2O6S (424.16679880000004)
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-2-methoxybenzenesulfonamide
C20H28N2O6S (424.16679880000004)
N-[(2R,3S,6R)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
C21H29ClN2O5 (424.17648940000004)
N-[(2R,3R,6R)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
C21H29ClN2O5 (424.17648940000004)
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
C20H28N2O6S (424.16679880000004)
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
C20H28N2O6S (424.16679880000004)
[(1S,2aR,8bR)-4-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-oxanyl)methanone
[(1R,2aR,8bR)-4-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-oxanyl)methanone
[(3aS,4S,9bS)-1-(benzenesulfonyl)-5-methyl-8-pent-1-ynyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol
C24H28N2O3S (424.18205380000006)
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-2-methoxybenzenesulfonamide
C20H28N2O6S (424.16679880000004)
N-[(2S,3S,6R)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
C21H29ClN2O5 (424.17648940000004)
N-[(2R,3R,6S)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
C21H29ClN2O5 (424.17648940000004)
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
C20H28N2O6S (424.16679880000004)
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
C20H28N2O6S (424.16679880000004)
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
C20H28N2O6S (424.16679880000004)
[(1S,2aS,8bS)-4-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-oxanyl)methanone
[(1R,2aS,8bS)-4-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-oxanyl)methanone
2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-alpha-D-galacto-hexopyranose
C16H28N2O11 (424.16930179999997)
[2-butyl-5-chloro-3-[[4-[2-(2,3-dihydro-1H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
(3alpha)-3-Hydroxy-12,13-epoxytrichothec-9-ene-4,8,15-triyl triacetate
3-Hydroxy-12,13-epoxytrichothec-9-ene-4,8,15-triyl triacetate
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3aS,10Z,11aR)-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate
(2S,4R)-N-[(1R)-2-chloro-1-[(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
C18H33ClN2O5S (424.17985980000003)
platencin(1-)
C24H26NO6 (424.17600360000006)
A monocarboxylic acid anion that is the conjugate base of platencin resulting from the deprotonation of the carboxy group; major species at pH 7.3.
Cleocin
C18H33ClN2O5S (424.17985980000003)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors
beta-D-GalpNAc-(1->4)-D-GlcpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide consisting of N-acetylglucosamine having an N-acetylgalactosaminyl resiude attached at the 4-position via a beta-linkage.
N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-aldehydo-D-glucosamine
C16H28N2O11 (424.16930179999997)
alpha-D-GalpNAc-(1->4)-beta-D-GlcpNAc
C16H28N2O11 (424.16930179999997)
An alpha-D-GalpNAc-(1->4)-D-GlcpNAc in which the reducing end anomeric centre has beta-configuration.
D-GalpNAc-(1->3)-D-GalpNAc
C16H28N2O11 (424.16930179999997)
A disaccharide composed of two 2-(acetylamino)-2-deoxy-D-galactopyranose units in (1->3) linkage.
2-Acetamido-2-deoxy-3-O-(2-acetamido-2-deoxy-B-D-glucopyranosyl)-D-galactopyranose
C16H28N2O11 (424.16930179999997)
beta-D-GalpNAc-(1->4)-alpha-D-GalpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide comprised of N-acetyl-alpha-D-galactosamine having an N-acetyl-D-galactosaminyl residue attached at the 4-position via a beta-linkage. Important epitope forming part of the O-polysaccharides of some Gram-negative bacteria.
alpha-D-GalpNAc-(1->3)-D-GalpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide consisting of two N-acetyl-D-galactosamine units joined via an alpha-(1->3)-linkage.
alpha-D-GalpNAc-(1->4)-D-GlcpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide consisting of N-acetyl-D-glucosamine having an N-acetyl-alpha-D-galactosminyl resiude attached at the 4-position.
alpha-D-GalNpAc-(1->3)-beta-D-GalpNAc
C16H28N2O11 (424.16930179999997)
An alpha-D-GalpNAc-(1->3)-D-GalpNAc having beta-configuration at the reducing end anomeric centre.
clindamycin
C18H33ClN2O5S (424.17985980000003)
A carbohydrate-containing antibiotic that is the semisynthetic derivative of lincomycin, a natural antibiotic.
N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine
C16H28N2O11 (424.16930179999997)
An N,N-diacetylchitobiose having beta-configuration at the reducing end anomeric centre.
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (3as,11ar)-10-methyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
5-hydroxy-3,6,9-trimethylidene-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
(2s)-2-(2,4-dihydroxyphenyl)-8-[(2z)-3,7-dimethylocta-2,6-dien-1-yl]-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one
3-(2,4-dihydroxyphenyl)-8-[(2z)-3,7-dimethylocta-2,6-dien-1-yl]-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one
7,11-dihydroxy-17-(2-hydroxypropan-2-yl)-13-methyl-6-(3-methylbut-2-en-1-yl)-2,15-dioxatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-3,5,7,10,12,14(18)-hexaen-9-one
(2s)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6,8-bis[(1e)-3-methylbut-1-en-1-yl]-2,3-dihydro-1-benzopyran-4-one
[8-(acetyloxy)-11-ethoxy-10-hydroxy-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-6-yl]methyl acetate
(2s,4ar,5s)-2,8,10-trihydroxy-2,5-dimethyl-5-(4-methylpent-3-en-1-yl)-4,4a-dihydro-3h-6-oxatetraphene-7,12-dione
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (3ar,11as)-6-methyl-3-methylidene-2-oxo-3ah,4h,7h,8h,11h,11ah-cyclodeca[b]furan-10-carboxylate
(3r)-2,2-dimethyl-5,10-dioxo-3h,4h-naphtho[2,3-b]pyran-3-yl (2e,6s)-6-hydroxy-2,6-dimethylocta-2,7-dienoate
butyl (1s,3r,4r,5r)-1,3,4-trihydroxy-5-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}cyclohexane-1-carboxylate
1,8-dihydroxy-3-{[(2e)-7-hydroxy-3,7-dimethyloct-2-en-1-yl]oxy}-6-methylanthracene-9,10-dione
(3r)-3-{5-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2,4-dihydroxyphenyl}-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one
(2s,7s)-2-{[(1s)-1-{[(1s)-1-carboxy-2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}ethyl]amino}-7-hydroxy-4-oxooctanoic acid
5,7-dihydroxy-2-[3-hydroxy-2,2-dimethyl-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-1-benzopyran-6-yl]-2,3-dihydro-1-benzopyran-4-one
(2s)-2-(2,4-dihydroxyphenyl)-8-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one
2-oxapentacyclo[22.2.2.1³,⁷.0¹⁰,¹⁵.0¹⁶,²¹]nonacosa-1(26),3(29),4,6,10,12,14,16,18,20,24,27-dodecaene-4,12,17-triol
(2r,11r,16s,17s)-17-methyl-17-(4-methylpent-3-en-1-yl)-4,12,18-trioxapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-1(21),5,7,9,13,19-hexaene-7,16,20-triol
(2s)-5,7-dihydroxy-2-[4-hydroxy-3-(2-hydroxy-3-methylbut-3-en-1-yl)-5-(3-methylbut-2-en-1-yl)phenyl]-2,3-dihydro-1-benzopyran-4-one
15-oxapentacyclo[20.2.2.2¹⁶,¹⁹.1¹⁰,¹⁴.0²,⁷]nonacosa-1(25),2,4,6,10,12,14(29),16,18,22(26),23,27-dodecaene-5,13,24-triol
(2z)-3-hydroxy-1-[(2s)-6-hydroxy-2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-yl]-3-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]prop-2-en-1-one
(1s,17s)-7,11-dihydroxy-17-(2-hydroxypropan-2-yl)-13-methyl-6-(3-methylbut-2-en-1-yl)-2,15-dioxatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-3,5,7,10,12,14(18)-hexaen-9-one
3-(2,4-dihydroxyphenyl)-3,7-dihydroxy-6,8-bis(3-methylbut-2-en-1-yl)-2h-1-benzopyran-4-one
(1's,2s,2'r,3's,4z,5'r,7'r,8's,9'r,12's)-2'-hydroxy-12'-(2-hydroxypropan-2-yl)-8'-methoxy-4-(1-methoxyethylidene)-7'-methyl-4',10'-dioxaspiro[oxolane-2,6'-tetracyclo[7.2.1.0²,⁷.0³,⁵]dodecane]-5,11'-dione
4,5-dihydroxy-6-[(2-hydroxycyclohexyl)oxy]-2-(hydroxymethyl)oxan-3-yl 3-(4-hydroxyphenyl)prop-2-enoate
[(2r,3s,4s,5r,6r)-6-[(3z)-hex-3-en-1-yloxy]-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
2,15-dioxapentacyclo[22.2.2.1³,⁷.1¹⁰,¹⁴.0¹⁶,²¹]triaconta-1(26),3(30),4,6,10(29),11,13,16,18,20,24,27-dodecaene-4,17-diol
(3as,5r,9ar,9bs)-5-hydroxy-6-methyl-3-methylidene-9-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3ah,4h,5h,7h,9ah,9bh-azuleno[4,5-b]furan-2-one
(3s)-3-(2,4-dihydroxyphenyl)-8-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one
(4s,12r)-8-hydroxy-12-(4-hydroxyphenyl)-4-(2-hydroxypropan-2-yl)-7-(3-methylbut-2-en-1-yl)-5,13-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),2(6),7-trien-10-one
(2s)-2-{5-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2,4-dihydroxyphenyl}-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one
(3s)-3-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6,8-bis(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
(10s)-4,10,15-trihydroxy-13-methyl-7-(3-methylbut-2-en-1-yl)-12-[(3-methylbut-2-en-1-yl)oxy]-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-2-one
3-(2,4-dihydroxyphenyl)-8-(3,7-dimethylocta-2,6-dien-1-yl)-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one
5-(acetyloxy)-9-hydroperoxy-6-hydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,6ah,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-methylpropanoate
(2s)-2-[2,4-dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl]-5,7-dihydroxy-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6,8-bis(3-methylbut-1-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
(2r,11r,16r,17r)-17-methyl-17-(4-methylpent-3-en-1-yl)-4,12,18-trioxapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-1(21),5,7,9,13,19-hexaene-7,16,20-triol
8-hydroxy-12-(4-hydroxyphenyl)-5-(2-hydroxypropan-2-yl)-2-(3-methylbut-2-en-1-yl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1(9),2,7-trien-10-one
(2s,4r)-n-{2-chloro-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl}-1-methyl-4-propylpyrrolidine-2-carboximidic acid
C18H33ClN2O5S (424.17985980000003)